Do NSAIDs inhibit growth of precancerous cervical cells in vitro?

Dussadee Sakonlaya1, Pirath Tapanadechopone, Auragun Poomkokruk

  • 1Department of Clinical Sciences, Faculty of Medicine, Thammasat University, Pathumthani, Thailand. dsmedtu@yahoo.com

Abstract

Insights

Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and celecoxib show promise in cervical cancer prevention. These drugs significantly inhibited growth and induced cell death in laboratory studies, suggesting potential for future clinical trials.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Cervical cancer is a global health concern.
  • Chemoprevention using Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is a novel strategy.
  • Limited in vitro data exists for NSAIDs' effects on cervical precancerous lesions.

Purpose of the Study:

  • To investigate the in vitro growth inhibitory effects of nonselective and selective NSAIDs on immortalized cervical cells.
  • To evaluate the impact of NSAIDs on cervical cell proliferation and apoptosis.

Main Methods:

  • Utilized Cell Proliferation (MTT) Assay to assess cytotoxicity of ibuprofen and celecoxib.
  • Employed Propidium Iodide (PI) Assay to analyze drug-induced apoptotic cell death.
  • Tested NSAIDs on immortalized cervical cell lines in vitro.

Main Results:

  • Ibuprofen and celecoxib demonstrated significant growth inhibition with IC50 values of 3.00 +/- 0.44 mM and 30.00 +/- 11.00 uM, respectively.
  • Both tested NSAIDs significantly induced apoptosis in immortalized cervical cells.
  • In vitro studies confirmed the cytotoxic and apoptotic effects of ibuprofen and celecoxib.

Conclusions:

  • Ibuprofen and celecoxib effectively inhibit growth and induce apoptosis in immortalized cervical cells.
  • These findings support further in vivo research and clinical trials for cervical cancer chemoprevention.
  • NSAIDs represent a potential avenue for novel cervical cancer prevention strategies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...